Api Details

Azacitidine is a vital pharmaceutical API utilized in the treatment of certain blood disorders, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). It belongs to the class of drugs known as hypomethylating agents, which work by inhibiting DNA methylation, thereby restoring normal cell function and slowing down the growth of cancer cells. Administered via injection, dosages vary based on the specific condition and individual response. While generally well-tolerated, potential side effects may include bone marrow suppression, nausea, and fatigue. Regulatory adherence ensures stringent quality and safety standards during manufacturing, ensuring reliability in Azacitidine-containing pharmaceutical products.